Advertisement

Topics

Dissolution Technologies Company Profile

11:45 EST 24th November 2017 | BioPortfolio

This site is a companion to Dissolution Technologies, a quarterly publication reporting relevant information on dissolution testing. It provides an international forum for open exchange of information on various dissolution topics

Location

9 Yorkridge Trail
Hockessin
DE 19707
Germany

Contact

Phone: 302-235-0621.
Fax: 443-946-1264
Email: vgray@dissolutiontech.com


News Articles [213 Associated News Articles listed on BioPortfolio]

TSI achève un essai clinique de phase 1 portant sur le TS01, nouvelle thérapie de dissolution ...

Ce système fibrinolytique de dissolution des caillots du corps humain recourt à deux enzymes naturels, à savoir l'activateur tissulaire du plasminogène (tPA) et la pro-urokinase Read more...

New EMA reflection paper on setting dissolution specifications

The European Medicines Agency (EMA) released a reflection paper on 15 August 2017 which will help generic drugmakers to set specifications for the in vitro dissolution of immediate-release oral drugs.

Global Drug Dissolution Tester Market Research Report Forecast 2017 to 2022 [Report Updated: 29062017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Drug Dissolution Tester Market Research Report Forecast 20172022 is a valuable source of insightful data for business s...

Predictive Dissolution Modeling: Next-Generation Development and Release Strategy

Defiant Hun Sen tells U.S. to cut all aid to Cambodia

Cambodian Prime Minister Hun Sen challenged the United States on Sunday to cut all aid after it announced it was ending funding for a general election next year in response to the dissolution of the m...

FDA issues bioequivalence guidelines

The FDA issued final guidelines for the bioequivalence testing of 46 products, specifying dissolution test methods, sampling  -More- 

Dissolution testing and dirty gaskets: US FDA warns Hetero Labs

The US FDA has sent a warning letter to Hetero Labs Limited citing GMP violations at its finished dose formulations facility in Telangana, India.

The Eclipse 5300 Dissolution Sampler by Distek, Has Now Received CE, ETL and FCC Mark Approval

The Eclipse 5300 has undergone certification with an accredited testing laboratory and has passed all the required testing standards for obtaining approval

PubMed Articles [501 Associated PubMed Articles listed on BioPortfolio]

Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products.

In vitro dissolution testing is routinely used in the development of pharmaceutical products. Whilst the dissolution testing methods are well established and standardized for oral dosage forms, i.e. t...

Lyophilic matrix method for dissolution and release studies of nanoscale particles.

We introduce a system with a lyophilic matrix to aid dissolution studies of powders and particulate systems. This lyophilic matrix method (LM method) is based on the ability to discriminate between no...

Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution.

Effects of three polymers, polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), and copolymer of vinyl pyrrolidone/vinyl acetate (PVP-VA), on the dissolution behaviour of the cocrystals of flufenami...

Health behaviors and union dissolution among parents of young children: Differences by marital status.

Previous research finds that marriage is associated with better health and lower mortality, and one of the mechanisms underlying this association is health-related selection out of marriage. Using lon...

Probing the oxidative etching induced dissolution of palladium nanocrystals in solution by liquid cell transmission electron microscopy.

A microscopic study of dissolution process of nanocrystals, an opposite while functioning cooperatively with growth in many cases, is an essential issue in variety aspects of research on nanocrystals....

Clinical Trials [344 Associated Clinical Trials listed on BioPortfolio]

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

This study will investigate the effect of Tafenoquine (TQ) 150 mg tablet ageing (dissolution profiles) on human exposure of TQ comparing the relative bioavailability of TQ from tablets exh...

Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis

The purpose of this study is to determine whether Renalof administration promotes partial or total dissolution of urinary calculi and improves physicochemical parameters and metabolic acti...

Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

Study to assess the relative Bioavailability To assess the relative bioavailability of three formulations of nifurtimox 30 mg tablets exhibiting different in vitro dissolution profiles To ...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Companies [1243 Associated Companies listed on BioPortfolio]

Dissolution Technologies

This site is a companion to Dissolution Technologies, a quarterly publication reporting relevant information on dissolution testing. It provides an international forum for open exchange of information...

Argonaut Technologies Inc

The Shareholders have voted for dissolution of the company. The vote was held and completed on March 21, 2011.

Distek, Inc.

In 2005, Distek will celebrate a 25 year tradition of quality and dependability by commemorating the release of our first dissolution tester, the Model 2000. Since our inception, Distek has retained ...

AuraZyme™ Pharmaceuticals

AuraZyme™ Pharmaceuticals is a development stage company founded to develop and commercialize therapeutic drug formulations that increase efficacy of drug therapy, lower drug dosage requirements, re...

pION Inc.

pION, a world leader in drug absorption measurement, specializes in the determination and prediction of solubility, dissolution, permeability and human absorption. pION also offers a range of instrume...

More Information about "Dissolution Technologies" on BioPortfolio

We have published hundreds of Dissolution Technologies news stories on BioPortfolio along with dozens of Dissolution Technologies Clinical Trials and PubMed Articles about Dissolution Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dissolution Technologies Companies in our database. You can also find out about relevant Dissolution Technologies Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record